Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS: CHGCY · Delayed Price · USD
16.62
+0.16 (0.97%)
May 3, 2024, 3:59 PM EDT - Market closed
Chugai Pharmaceutical Co. Revenue
Chugai Pharmaceutical Co. had revenue of 1.04T JPY in the twelve months ending March 31, 2024, down -14.49% year-over-year. Revenue in the quarter ending March 31, 2024 was 236.95B JPY, a -24.11% decrease year-over-year. In the year 2023, Chugai Pharmaceutical Co. had annual revenue of 1.11T JPY, a decrease of -11.79%.
Revenue (ttm)
1,036.08B JPY
Revenue Growth
-14.49%
P/S Ratio
8.08
Revenue / Employee
136,253,945 JPY
Employees
7,604
Market Cap
54.69B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,111.37B | -148.58B | -11.79% |
Dec 31, 2022 | 1,259.95B | 260.19B | 26.02% |
Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
Dec 31, 2019 | 686.18B | 106.40B | 18.35% |
Dec 31, 2018 | 579.79B | 45.59B | 8.53% |
Dec 31, 2017 | 534.20B | 42.42B | 8.63% |
Dec 31, 2016 | 491.78B | -7.06B | -1.42% |
Dec 31, 2015 | 498.84B | 37.73B | 8.18% |
Dec 31, 2014 | 461.11B | 37.46B | 8.84% |
Dec 31, 2013 | 423.65B | 32.43B | 8.29% |
Dec 31, 2012 | 391.22B | 17.70B | 4.74% |
Dec 31, 2011 | 373.52B | -5.99B | -1.58% |
Dec 31, 2010 | 379.51B | -49.44B | -11.53% |
Dec 31, 2009 | 428.95B | 102.01B | 31.20% |
Dec 31, 2008 | 326.94B | -17.87B | -5.18% |
Dec 31, 2007 | 344.81B | 18.71B | 5.74% |
Dec 31, 2006 | 326.10B | -1.06B | -0.32% |
Dec 31, 2005 | 327.16B | 32.49B | 11.02% |
Dec 31, 2004 | 294.67B | 61.92B | 26.60% |
Dec 31, 2003 | 232.75B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |